ATE158291T1 - Pharmazeutische verbindungen - Google Patents
Pharmazeutische verbindungenInfo
- Publication number
- ATE158291T1 ATE158291T1 AT94302040T AT94302040T ATE158291T1 AT E158291 T1 ATE158291 T1 AT E158291T1 AT 94302040 T AT94302040 T AT 94302040T AT 94302040 T AT94302040 T AT 94302040T AT E158291 T1 ATE158291 T1 AT E158291T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- optionally substituted
- hydroxy
- triazolyl
- phenyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 11
- -1 1-imidazolyl Chemical group 0.000 abstract 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 3
- 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000004185 ester group Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 2
- 125000001624 naphthyl group Chemical group 0.000 abstract 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 150000002825 nitriles Chemical class 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000001425 triazolyl group Chemical group 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939306062A GB9306062D0 (en) | 1993-03-24 | 1993-03-24 | Pharmaceutical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE158291T1 true ATE158291T1 (de) | 1997-10-15 |
Family
ID=10732627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94302040T ATE158291T1 (de) | 1993-03-24 | 1994-03-22 | Pharmazeutische verbindungen |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US5514699A (de) |
| EP (1) | EP0618206B1 (de) |
| JP (1) | JPH072845A (de) |
| AT (1) | ATE158291T1 (de) |
| CA (1) | CA2119530A1 (de) |
| DE (1) | DE69405624T2 (de) |
| DK (1) | DK0618206T3 (de) |
| ES (1) | ES2107129T3 (de) |
| GB (1) | GB9306062D0 (de) |
| GR (1) | GR3025637T3 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1004584A3 (de) * | 1992-11-18 | 2000-07-05 | Eli Lilly And Company Limited | Pyranochinolin Derivate als Inhibitoren der Zellproliferation |
| HRP960352A2 (en) * | 1996-07-26 | 1998-08-31 | Pliva Pharm & Chem Works | Novel coumarin quinoline carboxylic acids |
| AUPO227896A0 (en) * | 1996-09-13 | 1996-10-03 | Fujisawa Pharmaceutical Co., Ltd. | Novel compounds and their preparation |
| AU781986B2 (en) * | 1999-11-05 | 2005-06-23 | Cytovia, Inc. | Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| EP1392294A4 (de) * | 2001-05-16 | 2006-05-17 | Cytovia Inc | 7,8-kondensiertes 4$i(h)-chromen und analoga als caspase-aktivatoren und auslöser von apoptosis und ihre verewendung |
| EP1392283A4 (de) | 2001-05-16 | 2004-10-20 | Cytovia Inc | Substituierte cumarine und chinoline als caspase-aktivatoren |
| US6858607B1 (en) | 2001-05-16 | 2005-02-22 | Cytovia, Inc. | 7,8-fused 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| EP1392683B1 (de) | 2001-05-16 | 2009-12-02 | Cytovia, Inc. | Substituierte 4h-chromene und analoga als aktivatoren von caspasen und induktoren von apoptose, und deren verwendung als antikrebsmittel |
| US7476741B2 (en) | 2002-05-16 | 2009-01-13 | Cytovia, Inc. | Substituted 4H-chromens, 2H-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| CN100349887C (zh) * | 2002-05-16 | 2007-11-21 | 西托维亚公司 | 取代的4－芳基－4h－吡咯并[2,3－h]色烯和类似物及其药物组合物和用途 |
| CN107235954A (zh) | 2010-11-12 | 2017-10-10 | 德国癌症研究中心 | 作为Wnt通路拮抗剂的色烯衍生物及其类似物 |
| EP2776413A1 (de) | 2011-11-10 | 2014-09-17 | Memorial Sloan-Kettering Cancer Center | Behandlung von eierstockkrebs mit [2-amino-4h-naphtho-1,2-b-]pyran-3-carbonitrilen |
| KR102454815B1 (ko) * | 2018-02-21 | 2022-10-17 | 삼성전자주식회사 | 브라켓과 용량성 결합을 형성하고, 상기 브라켓에 배치된 복수의 회로 기판들의 접지부들과 전기적으로 연결된 도전성 부재를 포함하는 전자 장치 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2631710B2 (ja) * | 1988-08-16 | 1997-07-16 | 日本ヘキスト・マリオン・ルセル株式会社 | ピラノ〔ｆ〕キノリノン誘導体及び該化合物を有効成分とする医薬組成物 |
| ATE158288T1 (de) * | 1990-06-20 | 1997-10-15 | Upjohn Co | Antiatherosklerotische und antithrombotische 1- benzopyran-4-on- und 2-amino-1,3-benzoxazin-4-on- derivate |
| US5284868A (en) * | 1991-10-09 | 1994-02-08 | Eli Lilly And Company | Pharmaceutical compounds |
| GB9203497D0 (en) * | 1992-02-19 | 1992-04-08 | Lilly Industries Ltd | Pharmaceutical compounds |
| US5281619A (en) * | 1992-09-25 | 1994-01-25 | Eli Lilly And Company | Therapy for diabetic complications |
| EP1004584A3 (de) * | 1992-11-18 | 2000-07-05 | Eli Lilly And Company Limited | Pyranochinolin Derivate als Inhibitoren der Zellproliferation |
-
1993
- 1993-03-24 GB GB939306062A patent/GB9306062D0/en active Pending
-
1994
- 1994-03-21 CA CA002119530A patent/CA2119530A1/en not_active Abandoned
- 1994-03-21 US US08/215,344 patent/US5514699A/en not_active Expired - Fee Related
- 1994-03-22 AT AT94302040T patent/ATE158291T1/de not_active IP Right Cessation
- 1994-03-22 DK DK94302040.4T patent/DK0618206T3/da active
- 1994-03-22 DE DE69405624T patent/DE69405624T2/de not_active Expired - Fee Related
- 1994-03-22 ES ES94302040T patent/ES2107129T3/es not_active Expired - Lifetime
- 1994-03-22 EP EP94302040A patent/EP0618206B1/de not_active Expired - Lifetime
- 1994-03-23 JP JP6050918A patent/JPH072845A/ja active Pending
-
1995
- 1995-06-05 US US08/463,838 patent/US5574034A/en not_active Expired - Fee Related
- 1995-06-05 US US08/463,530 patent/US5576325A/en not_active Expired - Fee Related
- 1995-06-05 US US08/461,343 patent/US5571818A/en not_active Expired - Fee Related
-
1997
- 1997-12-10 GR GR970403289T patent/GR3025637T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5576325A (en) | 1996-11-19 |
| GB9306062D0 (en) | 1993-05-12 |
| GR3025637T3 (en) | 1998-03-31 |
| US5574034A (en) | 1996-11-12 |
| ES2107129T3 (es) | 1997-11-16 |
| CA2119530A1 (en) | 1994-09-25 |
| JPH072845A (ja) | 1995-01-06 |
| DE69405624T2 (de) | 1998-01-15 |
| EP0618206A1 (de) | 1994-10-05 |
| DE69405624D1 (de) | 1997-10-23 |
| EP0618206B1 (de) | 1997-09-17 |
| US5514699A (en) | 1996-05-07 |
| US5571818A (en) | 1996-11-05 |
| DK0618206T3 (da) | 1997-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69405624D1 (de) | Pharmazeutische Verbindungen | |
| FR16C1001I1 (fr) | "Dérivé de 2-oxo-1-pyrrolidine et ses applications pharmaceutique" | |
| AU2621692A (en) | 4H-naphtho(1,2-b)pyran derivatives and their use as pharmaceuticals | |
| ATE215371T1 (de) | Naphthyl substituierte benzimidazolderivate als antikoagulantien | |
| BG104441A (en) | Cyclic amine derivatives and their use as drugs | |
| IL95675A0 (en) | Pyrazole derivatives,processes for preparation thereof and pharmaceutical compositions containing the same | |
| GR3032972T3 (en) | Signal transmission and tag power consumption measurement circuit for an inductive reader. | |
| DK0809499T3 (da) | Visse 1,4,5-trisubstituerede imidazolforbindelser, der er egnede som cytokin | |
| IS2148B (is) | (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem COX-2 hindrar | |
| NO986055D0 (no) | Nye heterocykliske forbindelser, deres fremstilling, farmas÷ytiske preparat | |
| DE60117557D1 (de) | Pyrazolderivat, schädlingsbekämpfungsmittel, das dieses als wirkstoff umfasst und verfahren zu seiner herstellung | |
| MY109777A (en) | Pharmaceutical compounds therewith | |
| ES2131294T3 (es) | Compuestos herbicidas de pirrolo-piridina. | |
| DE69128630D1 (de) | Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält | |
| NO20023298D0 (no) | Nye imidazolderivater | |
| PT855398E (pt) | Derivados sasquiterpeno tendo actividade antiviral | |
| NZ275620A (en) | 3-optionally substituted phenyl or naphthyl-1,2,4-triazole derivatives; pharmaceutical compositions | |
| NO901630L (no) | Nye forbindelser. | |
| ATE154243T1 (de) | Hemmstoff der blutgefässhypertrophie | |
| JO1814B1 (en) | Therapeutic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |